-
Irish police prepare for further hoax bomb threats after hundreds of schools targeted
-
RBA Inflation Target Origins: Why Australia Chose a Range Over Zero
-
Korea, Singapore and New Zealand Advance Green Trade Pact Talks
-
Ireland and Ukraine consider drone cooperation memorandum after Dublin talks
-
Sister recounts fatal machete attack as Irish murder trial continues
-
Georgia refrigeration company sues EPA after five-year HFC reprieve
-
NEET’s Merit Promise Erodes as Cost and Time Barriers Rise for Medical Aspirants
-
Lakers Defeat Bucks 123-112 Amid Injury Concerns for Dončić and Reaves
-
HoloCoder technology promises brighter smartphone images and 3D depth data
-
The Good Daughter Streaming Guide: Release Date, Platforms, and Access
-
EU proposes broad consumer safeguards for apps, subscriptions and ticketing
-
Nvidia faces scrutiny over alleged Chinese intelligence link to Jensen Huang
-
Sophie Ellis-Bextor Announces 2027 Christmas Kitchen Disco Tour with Birmingham Stop
-
Radical Numerics develops offline AI tool to detect engineered pathogens
-
Chennai orders inquiry after dogs die at shelter; two veterinarians face action
-
Startup turns Chennai’s history and culture into an interactive world
-
Four firms compete to design Chennai’s model mobility corridors
-
Caledonia Mining Corporation Plc: ABRIDGED AND UNAUDITED QUARTERLY RESULTS AND DETAILS OF MANAGEMENT CONFERENCE CALL for the third quarter and nine months ended September 30, 2026 (the "Quarter" or "Q3 2026" and "Nine Months" respectively)
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 12
-
Hemogenyx Pharmaceuticals PLC Announces First Patient Treated in Second Adult Dose Cohort
-
Ocean Harvesters and Omega Protein Condemn Attacks on Commissioners and Fishing Families After Menhaden Vote
-
Chennai venue launches month-long festival devoted to full-length theatre
-
New Bay of Bengal low may form November 13 as Tamil Nadu outlook remains unclear
-
एलेक्स बोडी और SCANDIC PAY: Mastercard और VISA कार्ड — भुगतान की नई पीढ़ी
-
ALEX BODI och SCANDIC PAY: Mastercard- och VISA-kort – en ny generation betalningar
-
АЛЕКС БОДИ и SCANDIC PAY: карти Mastercard и VISA — ново поколение разплащания
-
알렉스 보디와 SCANDIC PAY: Mastercard·VISA 카드를 통한 차세대 결제
-
أليكس بودي وSCANDIC PAY: بطاقات Mastercard وVISA — جيل جديد من المدفوعات
-
ALEX BODIとSCANDIC PAY:Mastercard・VISAカードによる新世代の決済
-
ALEX BODI 與 SCANDIC PAY:Mastercard 與 VISA 卡——新一代支付方式
-
ALEX BODI a SCANDIC PAY: karty Mastercard a VISA – nová generace plateb
-
ΑΛΕΞ ΜΠΟΝΤΙ και SCANDIC PAY: κάρτες Mastercard και VISA — μια νέα γενιά πληρωμών
-
ALEX BODI i SCANDIC PAY: karty Mastercard i VISA — nowa generacja płatności
-
АЛЕКС БОДІ та SCANDIC PAY: картки Mastercard і VISA — нове покоління платежів
-
АЛЕКС БОДИ и SCANDIC PAY: карты Mastercard и VISA — новое поколение платежей
-
ALEX BODI and SCANDIC PAY: Mastercard and VISA Cards – A New Generation of Payments
-
ALEX BODI și SCANDIC PAY: Cardurile Mastercard și VISA – o nouă generație de plăți
-
AI Bots and Plagiarism: How Philadelphia and New Jersey News Sites Are Using Fake Content
-
UK House Prices Fall 1.2% as London Records Sharpest Annual Decline
-
The Dice Box Recommends Winter Board Games for Sneinton Market Lounge
GEON Performance Solutions Acquires Foster Corporation
Acquisition expands high-value medical platform
GEON® Performance Solutions, a global leader in the formulation, development and manufacture of performance polymer solutions, today announced it acquired Foster Corporation, a differentiated compounder of biomedical polymers used in the high-growth healthcare and medical device industry.
GEON Performance Solutions logo
"This strategic acquisition broadens GEON's portfolio of medical polymer solutions to offer a full spectrum of materials to medical companies," said GEON CEO Tracy Garrison. "Foster Corporation has an impressive 36-year track record of delivering highly innovative, market-leading technologies for life-saving medical devices. We are privileged to partner with their team to further strengthen and expand this tradition of excellence."
This is GEON's fourth acquisition since 2020 and its second acquisition in the last year - a key component of its strategy to enhance and diversify its portfolio of engineered polymer solutions and further expand its global footprint for customers. In December of 2023, GEON acquired PolymaxTPE, adding thermoplastic elastomer to its material portfolio.
The acquisition of Foster Corporation enhances GEON's participation in the high-value medical market. Currently, GEON offers rigid and flexible polyvinyl chloride (PVC) solutions, thermoplastic elastomer (TPE) solutions, and contract manufacturing services to healthcare customers. Its Clinton, Tennessee, facility is ISO 13485:2016 certified, which is the medical industry's international standard for the manufacture of medical devices. Foster Corporation, which is also ISO 13485:2016 certified, offers formulation, development and production of custom medical compounds, implantable materials, engineered polymers, thermoplastic polyurethane elastomers and polymer enhancements. It also offers a range of services in clean and white room manufacturing facilities.
"GEON is the ideal partner to leverage Foster's strengths and augment its capabilities to better serve unique customer needs," said President and CEO of Foster Corporation, Larry Acquarulo. "We are proud that Foster's commitment to quality and innovation will live on with GEON."
Foster Corporation is headquartered in Putnam, Connecticut, and has supply partnerships in Europe and Southeast Asia. The business operates three manufacturing locations and two distribution centers in the United States and employs approximately 200 people.
As part of GEON, Foster Corporation will be the face to the medical end market, including GEON's existing volumes, and will leverage GEON's development capabilities, salesforce and extensive capacity.
Benesch, Friedlander, Coplan, & Aronoff LLP acted as legal counsel for GEON. NorthView Advisors, LLC served as investment advisor to GEON. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. served as legal counsel for Foster, and Covington Associates, LLC served as the company's investment advisor.
About GEON Performance Solutions
GEON® Performance Solutions is a global leader in the formulation, development and manufacture of performance polymer solutions. With a portfolio of highly adaptable vinyl and polyolefin polymer technologies as well as a full-service manufacturing business, GEON combines three powerful traditions into a single, customer-focused business. GEON Performance Solutions is a leading innovator in the development of performance material solutions for a broad range of markets including appliances, building & infrastructure, electronics, medical, transportation, power & communications and more. GEON Performance Solutions has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Please visit us at www.geon.com to learn more. GEON Performance Solutions is a portfolio company of SK Capital Partners.
About SK Capital Partners
SK Capital is a private investment firm with a disciplined focus on the specialty materials, ingredients, and life sciences sectors. The Firm seeks to build resilient, sustainable, and growing businesses that create substantial long-term value. SK Capital aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. SK Capital's portfolio of businesses generates revenues of approximately $12 billion annually, employs more than 25,000 people globally, and operates more than 200 plants in over 30 countries. The Firm currently has approximately $9 billion in assets under management. For more information, please visit www.skcapitalpartners.com.
Contact Information
Renita Anderson
Vice President, Marketing & Business Development
[email protected]
678-772-8953
SOURCE: GEON Performance Solutions
W.Stewart--AT